
Yu-Wei Chang
Articles
-
Jan 20, 2024 |
medrxiv.org | Shuyang Yao |Fahimeh Darki |Yu-Wei Chang |Arvid Harder
PFS is a scientific consultant and shareholder for Neumora Therapeutics. JHL was supported by the Swedish Research Council (award 2018-00799), Swedish Brain Foundation (award FO2018-0272) and European Research Council (SCHIZTYPE, grant agreement 819540). PFS was supported by the Swedish Research Council (award D0886501) and the US National Institute of Mental Health (R01s MH124871, MH121545, and MH123724).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →